These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 25316440)

  • 1. The prognostic significance of p53 expression in gastric cancer: a meta-analysis.
    Wei K; Jiang L; Wei Y; Wang Y; Qian X; Dai Q; Guan Q
    J Cancer Res Clin Oncol; 2015 Apr; 141(4):735-48. PubMed ID: 25316440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinicopathological parameters and prognostic significance of HER2 expression in gastric cancer patients: a meta-analysis of literature.
    Lei YY; Huang JY; Zhao QR; Jiang N; Xu HM; Wang ZN; Li HQ; Zhang SB; Sun Z
    World J Surg Oncol; 2017 Mar; 15(1):68. PubMed ID: 28327158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic value of ERCC1 expression in gastric cancer patients treated with platinum-based chemotherapy: a meta-analysis.
    Wei KK; Jiang L; Wei YY; Wang YF; Qian XK; Dai Q; Guan QL
    Tumour Biol; 2014 Sep; 35(9):8721-31. PubMed ID: 24870596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic value of E-cadherin in gastric cancer: a meta-analysis.
    Xing X; Tang YB; Yuan G; Wang Y; Wang J; Yang Y; Chen M
    Int J Cancer; 2013 Jun; 132(11):2589-96. PubMed ID: 23169395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of p53 in gastric cancer: a meta- analysis.
    Yildirim M; Kaya V; Demirpence O; Gunduz S; Bozcuk H
    Asian Pac J Cancer Prev; 2015; 16(1):327-32. PubMed ID: 25640374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological and prognostic significance of HER2 overexpression in gastric cancer: a meta-analysis of the literature.
    Liang JW; Zhang JJ; Zhang T; Zheng ZC
    Tumour Biol; 2014 May; 35(5):4849-58. PubMed ID: 24449506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of p53 expression in patients with esophageal cancer: a meta-analysis.
    Wang L; Yu X; Li J; Zhang Z; Hou J; Li F
    BMC Cancer; 2016 Jul; 16():373. PubMed ID: 27370310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poor prognosis of phosphatase of regenerating liver 3 expression in gastric cancer: a meta-analysis.
    Hu L; Luo H; Wang W; Li H; He T
    PLoS One; 2013; 8(10):e76927. PubMed ID: 24204707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Prognostic and Clinicopathological Significance of Tumor-Associated Macrophages in Patients with Gastric Cancer: A Meta-Analysis.
    Yin S; Huang J; Li Z; Zhang J; Luo J; Lu C; Xu H; Xu H
    PLoS One; 2017; 12(1):e0170042. PubMed ID: 28081243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bcl-2 expression and patient survival in gastric cancer: a systematic review of the literature with meta-analysis.
    Cheng H; Wang X; Li T; Chen L
    Med Oncol; 2015 Jan; 32(1):389. PubMed ID: 25428392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal β-catenin immunohistochemical expression as a prognostic factor in gastric cancer: a meta-analysis.
    Li LF; Wei ZJ; Sun H; Jiang B
    World J Gastroenterol; 2014 Sep; 20(34):12313-21. PubMed ID: 25232267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic and clinical significance of VEGFR-3 in gastric cancer: A meta-analysis.
    Ge H; Yan Y; Guo L; He X; Yang X
    Clin Chim Acta; 2017 Nov; 474():114-119. PubMed ID: 28939099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The immunohistochemical expression of the p53-protein in gastric carcinomas. Correlation with clinicopathological factors and survival of patients.
    Lazăr D; Tăban S; Sporea I; Dema A; Cornianu M; Lazăr E; Goldiş A; Raţiu I; Vernic C
    Rom J Morphol Embryol; 2010; 51(2):249-57. PubMed ID: 20495739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors of lymph node metastasis in the splenic hilum of gastric cancer patients: a meta-analysis.
    Du J; Shen Y; Yan W; Wang J
    World J Surg Oncol; 2020 Sep; 18(1):233. PubMed ID: 32873315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparanase mRNA and Protein Expression Correlates with Clinicopathologic Features of Gastric Cancer Patients: a Meta- analysis.
    Li HL; Gu J; Wu JJ; Ma CL; Yang YL; Wang HP; Wang J; Wang Y; Chen C; Wu HY
    Asian Pac J Cancer Prev; 2015; 16(18):8653-8. PubMed ID: 26745132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of Muc5AC in gastric cancer: A meta-analysis.
    Zhang CT; He KC; Pan F; Li Y; Wu J
    World J Gastroenterol; 2015 Sep; 21(36):10453-60. PubMed ID: 26420972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD44v6: A metastasis-associated biomarker in patients with gastric cancer?: A comprehensive meta-analysis with heterogeneity analysis.
    Lu L; Huang F; Zhao Z; Li C; Liu T; Li W; Fu W
    Medicine (Baltimore); 2016 Dec; 95(50):e5603. PubMed ID: 27977599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological and prognostic significance of FoxM1 in gastric cancer: A meta-analysis.
    Jiang D; Jiang L; Liu B; Huang H; Li W; Zhang T; Zu G; Zhang X
    Int J Surg; 2017 Dec; 48():38-44. PubMed ID: 29017864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of p53 protein expression in early gastric cancer.
    Gonçalves AR; Carneiro AJ; Martins I; de Faria PA; Ferreira MA; de Mello EL; Fogaça HS; Elia CC; de Souza HS
    Pathol Oncol Res; 2011 Jun; 17(2):349-55. PubMed ID: 21116760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of p53, nm23, PCNA and c-erbB-2 in gastric cancer.
    Lee KE; Lee HJ; Kim YH; Yu HJ; Yang HK; Kim WH; Lee KU; Choe KJ; Kim JP
    Jpn J Clin Oncol; 2003 Apr; 33(4):173-9. PubMed ID: 12810831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.